2Daxboeck F, Bauer CC, Assadian O, et al. An unrecognized epidemic of Mycoplasma pneumoniae infection in Vienn. Wien Klin Wochenschr,2006,118(7-8) :208 - 11.
3Roger Dumke, Paul Christian Luack, Christoph Noppen, et al. Culture-Independent Molecular Subtyping of Mycoplasma pneumoniae in Clinical Samples. Journal of clinical microbiology,2006,44 (7) : 2567 - 2570.
4Musatovova O, Kannan TR, Baseman JB, et al. Genomic analysis reveals Rep MP1-mediated recombination in Mycoplasma pneumoniae clinical isolate. Infect Immun,2008,22.
5Shankar EM, Kumarasamy N, Vignesh R, et al. Epidemiologieal studies on pulmonary pathogens in HIV-positive and-negative subjects with or without community-acquired pneumonia with special emphasis on Mycoplasma pneumoniae. Jpn J Infect Dis, 2007,60 (6) :337 -41.
6Hugosson A, Hjorth M, Bemander S, et al. A community outbreak of Legionnaires'disease from an industrial cooling tower: assessment of clinical features and diagnostic procedures. Scand J Infect Dis, 2007,39 (3) :217 - 24.
7Zahariadis G, Gooley TA, Ryall P, et al. Risk of ruling out severe acute respiratory syndrome by ruling in another diagnosis: variable incidence of atypical bacteria coinfection based on diagnostic as- says. Can Respir J, 2006,13 ( 1 ) : 17 - 22.
8Klement E, Talkington DF, Wasserzug O, et al. Identification of risk factors for infection in an outbreak of Mycoplasma pneumoniae respiratory tract disease. Clin Infect Dis,2006,43 (10) :1239 -45.
9Shen YH, Hwang KP, Niu CK, et al. Complicated parapneumonie effusion and empyema in children. J Microbiol Immunol Infect,2006, 39(6) :483 -8.
10Daxboeck F, Eisl B, Burghuber C, et al. Fatal Mycoplasma pneumoniae pneumonia in a previously healthy 18-year-old girl. Wien Klin Wochenschr,2007,119 ( 11-12 ) :379 - 84.
4Krausse R, Schubert S. In-vitro axtivities of tetracyclines, macrolides,fluoroquinolones and clindamycin against My-co plasma hoinis and Ureaplasma ssp. isolated in Germany over 20 yearsrJ~. Clin Mierobiol In{eet, 2010,16(11) : 1649-1655.
